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The development of the brightest luminescent europium(III) complexes is traced, including 
analysis of the C3-symmetric core complex based on a functionalized triazacyclononane and 
identification of the most suitable strongly absorbing chromophore. Strategies for the 
synthesis of the complexes, including enantiopure analogues, are outlined and opportunities 
for applications in time-resolved microscopy and spectral imaging emphasised. Practicable 
examples are introduced, including selective organelle staining for cellular optical imaging at 
65 nm resolution and the development of new bioassays using time-resolved FRET methods.  
 
Introduction   
In 1852, George Stokes introduced the word fluorescence to describe the phenomenon of 
‘internal reflection’ – an emission of blue light - that he had observed when examining sunlit 
samples of the mineral fluorspar, and that Herschel, Brewster and Becquerel had described 
earlier when irradiating solutions of quinine salts. 
1
 The calcium fluorite samples Stokes 
examined were doped with Eu(II), and led to a blue emission; with an Yb(II) dopant, yellow-
green light is emitted. 
2
 These beautiful mineral samples are still being mined in upper 
Weardale, County Durham in the North-East of England, and create a regional link to the 
series of very bright, red-emitting Eu(III) complexes described herein. 
 
Europium emission occurs on a millisecond timescale over the range 580 to 720 nm, and has 
been used for many years in a wide range of applications in the materials and biosciences, 
3-7
 
from security printing in bank notes to reporters for time resolved bioassays. As the 
transitions between f electronic energy levels are symmetry forbidden, direct excitation of the 
Eu ion is very inefficient, and the 
5
D0 Eu excited state is preferably populated via a 
sensitisation mechanism. This process involves light absorption by a proximate chromophore, 
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followed by intramolecular energy transfer to the Eu ion. In order that the Eu ion emits light 
with a high overall quantum yield in water, it needs to be efficiently shielded from the 
external environment, to minimize non-radiative deactivation processes, such as electron 
transfer or vibrational energy transfer to overtones of XH oscillators (X = O, N and C). 
8
 
Thus, the ligand used to complex the Eu ion must be octa- or nonadentate to exclude 
coordinated water molecules and should encapsulate the metal ion effectively. The brightness, 
B (), of the complex is the key parameter to maximize in this context. It is usually defined as 
the product of the molar extinction coefficient, , at exc and the overall quantum yield for Eu 
emission, em ,  in the background medium used.  For excitation at 337 or 355 nm in aqueous 
solutions, typical values of B for Eu complexes lie in the range 1 to 3 mM
-1
cm
-1
 
3,5,9,10
 
compared to the value of 13 mM
-1
cm
-1 
(exc 350 nm), reported
 
for the terbium cryptate, 
Lumi4-Tb
R
 
11
 used as a donor (em 488, 545, 590 nm) in a variety of time-resolved FRET 
assays. 
4a
  
 The long-lived nature of Eu emission allows its selective detection in time-resolved 
measurements, avoiding the experimental complications that may occur from light scattering 
or interference from endogenous fluorescence. For applications in optical imaging using 
luminescence microscopy, probe brightness needs to be assessed with due consideration to 
the time-resolved measurement and the local concentration of the probe, by using the 
following expanded relationship for probe brightness, B', eq. 1: 12 
 
        (1) 
 
 
 
When applied to cellular imaging, c is the complex loading concentration, λ is the 
excitation wavelength, k is the radiative rate constant for emission and η is an 
accumulation parameter, reflecting the amount of complex internalised.  The integral has 
limits (tacq + td) and td;  tacq is the spectroscopic integration or microscopic acquisition 
time and td is the delay time,  following pulsed excitation.  
 
Design criteria for very bright europium complexes 
Given that Eu(III) most commonly adopts a coordination number of nine, nonadentate ligands 
have been often considered and can be based on various C3 symmetric core structures, such as 
acyclic triamines or triaza-macrocycles, e.g. triazacyclononane (9-N3).  The 9-N3 macrocyclic 
ring is conformationally rigid and its chelate bite is matched to the requirements of small 
octahedral ions (e.g. Fe(III), Ga(III), Ni(II), Co(III)) 
13,14 
as well as larger lanthanide ions 
capable of adopting a tri-capped trigonal prismatic coordination geometry.
15
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Scheme 1 The essential design elements and structural features in emissive Eu probe design. 
 
The primary binding free energy term in Eu(III) coordination complexes is Coulombic. The 
tripositive ion therefore favours complexation with a trianionic ligand to enhance complex 
stability; ionized carboxylates, phosphinates and phenolates can be considered as preferred 
donors.  The latter two series afford a greater steric demand around the Eu ion, and variation 
of the substituent at P or on the phenolate ring controls the extent of shielding of the excited 
Eu ion,  (Scheme 1), inhibiting collisional deactivation processes.  The spectral form of Eu 
emission is a sensitive function of local complex symmetry and donor atom polarisability 
(vide infra). 
3,16-18
    
The imposition of local C3 symmetry, coupled with the introduction of more polarisable 
ligand donors (e.g. py-N > amine-N > O; carboxylate O > phosphinate O), leads to enhanced 
emission intensity of the electric-dipole allowed transitions around 610-620 nm (
5
D0 to 
7
F2) 
and to lower relative intensity in the other emission bands from the non-degenerate 
5
D0 
excited state.  
 relaxed
ICT state
5D0
7F0
7F4
7F2
5D1
S0
S1
T1
kabs
kISC
keT
klum
sensitising chromophore
E/ cm-1
europium (III)
17,200
19,000
3,000
'initial' ICT state
kabs
 
Scheme 2   Simplified Jablonski diagram illustrating sensitised emission of Eu(III), via an  
     intermediate chromophore triplet or a solvent-relaxed internal charge transfer excited state. 
     Cases of direct energy transfer from a singlet excited state have also been reported.
19
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In sensitized emission, the structure of the chromophore requires careful consideration in 
order to define the excitation wavelength, maximize absorbance at this wavelength and 
facilitate intramolecular energy transfer to populate the Eu(III) excited state. Given that 
common lasers operate at 337 and 355 nm, powerful laser-driven white light sources operate 
from 380 nm and low-cost LEDs function at 365 and 385 nm, these are the preferred target 
excitation wavelengths. Until recently, most chromophores were designed based on the 
premise that the mechanism of Eu excitation involved a triplet excited state, with an energy of 
>19,000 cm
-1
  (Eu 
5
D0 and 
5
D1 excited states lie at 17,200 and 19,000 cm
-1
, Scheme 2), a 
small singlet-triplet energy gap to favour intersystem crossing and a relatively high 
chromophore oxidation potential, to minimize charge transfer quenching of the singlet excited 
state by the proximate Eu(III) ion. 
3,9,19
 Following the definition of pyridyl-alkynyl-aryl 
chromophores (Scheme 1) with an intense internal charge transfer (ICT) transition, tunable by 
substitution of the aromatic groups, an expanded series of chromophores has emerged, each 
with an extinction coefficient of about 20 mM
-1
cm
-1
 
20,21
 (Scheme 2).  Energy transfer to a Eu 
ion, coordinated by one or more of the pyridyl N atoms is very efficient, and the 9-N3-based 
tris-pyridyl-alkynyl-aryl Eu complexes possess a brightness of around 15 to 30 mM
-1
 cm
-1
 in 
water or methanol following excitation in the range 337 to 360 nm. 
12,21
 Such a value for 
probe brightness is higher than for the red fluorescent protein mCherry (15.8 mM
-1
cm
-1
). 
22
 
  The ease of ligand synthesis and of structural permutation is an important 
final aspect in probe design, (Scheme 1).  For example, the ability to tune complex 
hydrophilicity and to enable linkage to targeting groups or to permit bio-conjugation are 
essential requirements in devising a family of complexes.  The more obvious linkage points to 
the core structure, described above, are on the 9-N3 ring carbon, thereby introducing a 
stereogenic centre, or on the peripheral aryl groups, such as via the alkoxy substituents. In the 
latter case, desymmetrisation of the complex requires that one of the alkynyl moieties be 
distinguished from the other two. In this regard, the intermediacy of mono-BOC-9-N3 permits 
selective dialkylation and allows the third added chromophore group to be permuted. 
23 
 
 
Structural Analysis of Europium Complexes in C3 Symmetry    
 The structures of the parent Eu complexes,  [Eu.L
1-3
], with three carboxylate, phosphinate or 
amide donors, have been determined by X-ray crystallography, (Figure 1); in each case an 
isostructural series was defined across the whole 4f block series. 
24-27
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Figure 1     Views from below, into the 9-N3 ring for the C3 symmetric X-ray structures of  
Upper left: -[Eu.L1]; upper right: -[Eu.L2] (i.e the R isomer); lower S-∆-(λλλ)-[EuL3]3+ (left) 
and R-Λ-(δδδ)-[EuL3]3+ (right) (120 K) (CCDC numbers: 206375-8; 836097-102; 965909-11) 24-27 
 
 
In these structures, the europium ion adopts a tricapped trigonal prismatic geometry, and each 
complex exists as a  racemate in solution. Resolution of the triphosphinate and 
tricarboxylate complexes by chiral HPLC has been achieved 
28
, and the half-lives for 
racemisation at 333K in water were 185(±20) and 245(±35) hours respectively, compared to 5 
milliseconds for the tris-chelate complex -[Eu(DPA)3]
3-
 (DPA = pyridine-2,6-dicarboxylate 
or dipicolinate) measured under the same conditions; dissociative ligand exchange provides a 
much faster pathway for racemisation of the tris-chelate complex.   
 
The introduction of an S chiral substituent on the amide moiety in [Eu.L
3
]
3+
 induced 
preferential formation of the  complex, with an isomer ratio of 7:1 () being observed in 
solution by 
1
H NMR. Complete stereocontrol leading to preferential formation of one 
enantiomer was observed following introduction of a chiral centre directly onto the 9-N3 ring. 
Thus, a C-alkyl (alkyl = Me, 
i
Pr or benzyl) 9-N3 platform derived from an R amino-acid 
precursor
29
 led to formation of the  complex only, confirmed by NMR and HPLC analyses.28   
 
  
Dalton Trans Perspective 2014 
 6 
    
 
 
 
 
 
 
 
Figure 2       upper: Crystal structure of SSS- [Eu.L4] (CCDC 948247)28 ; lower: (a) the 
pseudo-equatorial positions of the pro-R hydrogens on the ring; (b) the corner position of the pro-R 
hydrogen (filled arrow where a C-substituent will prefer to reside), vs the side position of the pro-R 
hydrogen (dashed arrow); (c) the ring torsional angles - ‘corner’ carbons are marked with *  (i.e. those 
sites between two gauche bonds, thereby defining the rigid quadrangular [333] ring conformation). 
 
The very high stereoselectivity (>97%) observed in complex formation for the ring C-
substituted series of triazacyclononane complexes was rationalised by considering the X-ray 
structure of the para-bromo derivative, [Eu.L
4
]. The enantiomer shown (Fig. 2) has an S 
configuration at phosphorus and the complex helicity is Δ (or P).  The  configuration was 
shown by CPL and CD studies to be formed in complexes with an R-stereogenic centre at the 
ring carbon.  In this case, the pro-R hydrogen atom, which is the site where the ring 
substituent would reside, is in one of two pseudo-equatorial positions (Fig. 2a). To minimize 
steric repulsion, the most likely site occupied by the C-substituent is that directed away from 
the three pyridyl arms (Fig. 2b), consistent with substitution of a corner (rather than a side) 
carbon atom (Fig. 2c).  
 
The structure of the p-methoxyphenyl-alkynyl-pyridyl complex, [Eu.L
5
] has been reported. 
23,
     
In this case the complex was slightly distorted from C3 symmetry, and the phosphorus phenyl  
substituents were directed away from the plane of the 9-N3 ring to create a significant steric 
barrier (Figure 3). In agreement with this observation, the emission lifetime of the Eu(III) ion 
in [Eu.L
5
] was 30% longer than the carboxylate analogue in water, 
21
 consistent with reduced 
local quenching by closely diffusing waters and an increased complex rigidity.   
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Figure 3  Experimental X-ray (bold) and DFT calculated (ghost: Y analogue) structures for the 
p-methoxyphenyl-alkyne derivative, [Eu.L
5
], highlighting the steric bulk afforded by the three P-
phenyl substituents that shield the upper face of the complex (CCDC 857545). 
21,23
   
 
Synthesis of the chromophores and complexes 
A simple retrosynthetic analysis of the ligands in the target Eu complexes, such as [Eu.L
5
], 
reveals that the key reactions involve creation of a C-C bond between a 4-substituted pyridine 
and an aryl substituted  alkyne, and a C-N bond-forming reaction between the ring N and a 
suitable alpha-substituted pyridylmethyl electrophile. A representative synthesis of a 2,4,6- 
trisubstituted pyridine (Scheme 3) highlights the early introduction of the C-P bond, via 
palladium catalysed insertion into a P-H bond, followed by intramolecular CH activation of 
the ring methyl group, via a Boekelheide rearrangement of the intermediate pyridine N-oxide. 
A Sonogashira coupling reaction generates the conjugated alkyne, and subsequent mesylation 
provides the required electrophile to alkylate the 9-N3 ring. 
12,21,23 
 
 
 
  
  
 
 
 
  
 
 
 
Scheme 3 Synthesis of a typical 2,4,6-trisubstituted pyridine intermediate. 
12,21,23
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 Scheme 4     Synthesis of the tris-glucamide derivative, [Eu.L
6
]. 
12,30
    
 
The linear forward synthesis of a complex functionalized in the phenyl alkoxy group (Scheme 4) is 
typical of more than a dozen examples in which the Eu(III) ion is introduced in the final step, and the 
neutral complex is readily purified by reverse phase HPLC. An alternative, more divergent, strategy 
has been implemented wherein the 4-bromopyridyl europium complex, [Eu.L
4
] is used as a common 
intermediate (Scheme 5). This strategy allows the synthesis of a wide range of complexes with 
different aryl-alkynyl moieties, using the Sonogashira reaction in a product-forming step. 
31 
 
 
 
 
 
 
  Scheme 5 Retrosynthetic analysis revealing a divergent route, and an example of the synthesis 
  of an S-lysine derived enantiopure complex, -[Eu.L7]. 31 
 
Photophysical properties of europium complexes  
The emission spectral form of the parent complexes, [Eu.L
1-3
], strongly resembles that of 
[Eu(DPA)3]
3-
, with a ratio of intensities of the ΔJ = 2/ΔJ = 1 bands (around 616 and 590 nm: 
Dalton Trans Perspective 2014 
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Scheme 2) of between 4 and 5 to one in each case. In contrast, for the C3-symmetric 
complexes [Eu(ODA)3]
3-
 and [Eu(IDA)3]
3-
 (ODA = oxydiacetate; IDA = iminodiacetate; DPA 
= 2,6-pyridine-dicarboxylate),
32
 in which the same number of transitions is observed, the ΔJ = 
2/ΔJ = 1 intensity ratio is near unity for [Eu(ODA)3]
3-
 and 2.5:1 for [Eu(IDA)3]
3-
, (Figure 4).  
With the extended alkynyl-aryl complexes, the nature of the phosphorus substituent (Me vs 
Ph) does not change the spectral form significantly (Fig. 4 C vs D), although one of the J = 2 
transitions around 620 nm is much stronger than in [Eu(DPA)3]
3-
.   
  
Figure 4.  Comparison of total emission spectra for C3-symmetric Eu(III) complexes: A) [Eu(IDA)3]
3-
 
(λexc = 395 nm, H2O, pH 8.5); B) [Eu(DPA)3]
3-
 (λexc = 395 nm H2O, pH 8.5); C) [Eu.L
9b
]
3-
 (λexc = 322 
nm, H2O, pH 7.4); D) [Eu.L
6
] (λexc = 332 nm, H2O, pH 7.4)
12,23,32
  
In europium emission spectra, the oscillator strength of the ΔJ = 1 transitions (around 590 
nm) is magnetic-dipole (MD) allowed and independent of the ligand environment. In contrast, 
the ΔJ = 2 transitions (around 615 nm) are electric-dipole (ED)-allowed and hypersensitive to 
ligand perturbation. This behaviour can be rationalised in terms of a ligand polarization 
model
16
 wherein electric-quadrupole-allowed transitions (e.g. 
5
D0 to 
7
F2) gain significant ED 
strength via a quadrupole (Ln
3+
)-induced dipole (ligand donor) coupling mechanism.  Induced 
dipoles on the ligands are created by direct coupling to the ED components of the radiation 
field. Thus, 4f−4f ED strength can be related to ligand dipolar polarisabilities and to the 
anisotropies of these polarisabilities.
17
 Among the ligand donors considered, the polarizable 
pyridyl groups are common and predominantly define the ΔJ = 2 transition oscillator strength. 
Comparing [Eu.L
1
] and [Eu.L
2], very similar spectra were observed but the ΔJ = 2/ΔJ = 1 
intensity ratio was 20% higher, consistent with the greater polarisability of the carboxylate 
over the phosphinate oxygens.  
Dalton Trans Perspective 2014 
 10 
 
 
Figure 5          Selected europium complexes of varying charge and hydrophilicity (Table 1). 
12,21,27,33
  
 
The extinction coefficients of the Eu complexes with extended alkynyl groups lies in the 
range 55 to 60 mM
-1
cm
-1
 in water, with lifetimes of around 1 ms and emission quantum yields 
of 22 to 37%, giving brightness parameters, B(337 nm), of 10 to 22 mM
-1
cm
-1
, (Table 1).  
These are the highest values reported for emissive lanthanide complexes in solution.  
 
Table 1 Selected photophysical and hydrophilicity data for the europium complexes [EuL6] 
and [EuL
8-13
] (H2O, 295 K) 
12,27,33a
 
 
 
Complex 
 
 
 /ms 
 
 /mM-1 cm-1 
 
em /% 
 
log Pa 
 
[Eu.L6] 
 
1.07 
 
56.5 
 
26 
 
n.d. 
 
[Eu.L8] 
 
1.03 
 
58.1 
 
24 
 
+1.4 
 
[Eu.L9]3- 
 
1.04 
 
56.6 
 
26 
 
-2.2 
 
[Eu.L11]3- 
 
1.01 
 
56.8 
 
26 
 
-2.2 
 
[Eu.L12]3+ 
 
0.80 
 
56.5 
 
37 
 
+0.9 
 
[Eu.L13]3- 
 
1.11b 
 
58.0 
 
31b 
 
-0.7b 
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a  The log P data refer to the distribution of the complex between water and octan-1-ol; b the meta-sulfonated 
isomer has a log P  value of -1.4, an emission quantum yield of 33% and a lifetime in water of 1.12 ms. 33b  
 
Earlier seminal work in Lyon with tris-dipicolinate complexes possessing arylalkynyl 
substituents, showed that europium sensitisation involved an intramolecular energy transfer 
process involving a relaxed and broad ICT excited state, particularly for strongly conjugated 
electron-donating groups in the aryl group.
20b
 In the case of weaker electron releasing groups, 
the ICT state lies at higher energy and consequently a contribution from the classical triplet 
mediated sensitisation process remains possible.
20a
 Variable temperature phosphorescence 
measurements on the analogous gadolinium 9-N3 complexes clearly indicated the presence of 
a triplet excited state at approximately the same energy as the ICT state, (viz. Scheme 2, 
above). Thus, two sensitisation pathways, namely the triplet state mediated or the direct ICT 
process could be simultaneously involved in europium sensitisation. 
21
 Whatever the 
mechanism, the Eu complexes show excellent stability with respect to photobleaching, 
following laser excitation at 355 nm.
12
 Such behaviour contrasts with the instability of many 
organic dyes or of metal complexes bearing sensitisers which have an excited state with n* 
character. 
8 
Furthermore, these Eu complexes show no sensitivity to dissolved oxygen, unlike  
many of the emissive Re, Ru, Ir and Pt coordination complexes that are being intensively 
studied, where the triplet character of the charge transfer excited state usually leads to local 
formation of singlet oxygen, giving rise to severe probe toxicity.
25
  
 These chiral Eu complexes are excellent candidates for study using circularly 
polarized luminescence (CPL) spectroscopy. 
26-28,31,34,35  
 The use of CPL spectroscopy allows 
spectral resolution (Figure 6) of the observed transitions, notably in the J = 2 and 4 
manifolds, for the two examples shown here using [Eu.L
2
] and [Eu.L
7
]. The very high 
brightness of [Eu.L
7
] (B(355 nm) = 32 mM
-1
cm
-1
 in MeOH, 295K) allowed spectral 
acquisition in a few minutes using a 3 micromolar solution of the complex. 
31
 Such enhanced 
sensitivity with this new range of probes augurs well for the implementation of CPL 
microscopy, to track the fate of the enantiopure Eu probes and signal any changes in their 
chiral environment. Proof of principle studies have already demonstrated changes in complex 
helicity as a result of selective binding to an abundant endogenous chiral anion (e.g. lactate) 
or a well-defined site in a common protein, e.g. albumin or 1-AGP. 
34-38
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Figure 6  Circularly polarized luminescence spectra for: left, -[Eu.L2] (blue) and the  isomer 
(red) (50M, H2O, 295K, exc 280 nm); right,  (blue) and  (red) [Eu.L
7
] (3 M, 295K, MeOH, exc 
360 nm), showing the enhanced spectral resolution, e.g. for the J = 4 transitions around 700 nm (viz. 
Fig. 4 [C and D] above). 
25,26,31 
 
Cellular optical imaging 
The neutral and cationic Eu complexes (Figure 7) are taken into mammalian cells quite 
efficiently by macropinocytosis 
12,23
, a process that is promoted by addition of phorbol esters 
and inhibited by amiloride and wortmannin.
39
 Macropinocytosis is a form of endocytosis that 
leads to the formation of leaky macropinosomes of irregular size and shape, the contents of 
which are readily released into the cytoplasm. This pathway is an attractive means for 
delivery of the luminescent complexes into the cell, as the complexes can readily escape from 
the macropinosome, allowing vesicular trafficking to other compartments.  
The complexes are well tolerated by a wide variety of primary and transformed cell lines, 
with IC50 values (half maximal inhibitory concentration for 50% cell death at 24h) generally 
greater than 100 M. Cell uptake can be quantified by measuring the internalised Eu by ICP-
mass spectrometry, and the high brightness means that the concentration of the complex in 
the incubation medium usually needs to be in the range 500 nM to 20 M. Uptake in plant 
cells, roots and pollen tubes has also been studied, and [Eu.L
15
]
-
 was shown to act as a useful 
probe to label the cell walls of plants or root hairs.
40
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Figure 7  Examples of functionalized Eu complexes, including selected conjugates 
12
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The intracellular localization profile of the complexes shown above (Fig. 7) has been studied, and 
examples of complexes selectively staining the mitochondria (e.g. [Eu.L
6
], late endosomes/lysosomes 
(e.g. [Eu.L
9a
]
3-
) and the endoplasmic reticulum (e.g. [Eu.L
16
]
6+
) were identified.  A consequence of the 
high brightness of the probes is that there is sufficient signal to permit rapid acquisition of both the Eu 
spectral image and the lifetime of the complex, when internalized inside the cell. Such studies, using 
time-resolved CCD detection, allow the speciation of the Eu complex to be identified; in the majority 
of cases these reveal the same spectral fingerprint and lifetime as that measured in vitro. Such 
experiments confirm the integrity of the probe when localised inside the cell, (Figure 8) and an absence 
of change in lifetime confirms resistance to excited state quenching by endogenous electron rich 
species, such as protein Tyr residues, urate, ascorbate and related reducing agents. 
41
  
 
 
 
 
Figure 8       top: view of the mitochondrial network (at 65 nm resolution, using phase-modulated 
confocal microscopy) of an NIH-3T3 cell stained with the tris-glucamide complex, [Eu.L
6
]; middle: 
confocal microscopy images showing: left- the DAPI stained nucleus (exc 355 nm, m 400−450 nm); 
centre- MitoTracker Green staining of the mitochondrial network (xc 488 nm, em 500−530 nm); 
right- mitochondrial localisation of [Eu.L
6
] in NIH 3T3 cells (4h, 30 μM, exc 355 nm, em 605–720 
nm); lower: a merged image showing co-localisation (P = 0.89); lower right: spectral profiling of 
[Eu.L
6
] (24h, 30 μM), and the intracellular lifetime (Eu = 1 ms; 24h, 30 μM). 
12
 
 
 Consideration of Abbé’s law, (d = /2(n sin), where nsin is the numerical aperture (NA) = 
1.4 here,  is the excitation wavelength and d is the theoretical resolution) reveals that the use 
of 488 nm vs 355 nm excitation improves the intrinsic lateral resolution of confocal 
microscopy from 174 to 126 nm. The images obtained in Figure 8 accord with that view, and 
the recent use of a phase modulated resolution enhancement technique has allowed 
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microscopic resolution of 65 nm to be achieved. 
12
 As a result of the high intrinsic brightness 
of these Eu probes, the power used in pulsed excitation was only 4 mW (<80 
nJ/voxel/acquisition). These conditions are very different from those used in the past to 
examine and quantify UV damage to cells, where continuous light exposure persists for 
several seconds or minutes and the impact is a steep function of the excitation wavelength.  
Much less damage occurs above 340 nm.
42
 Indeed, in control experiments examining healthy 
mouse skin fibroblasts (NIH-3T3 cells) loaded with [Eu.L
6
] (400 nM), following sequential 
scanning excitation at 355 nm (6 mW) with a 63x objective (NA = 1.4), scanning the same 
area every 30 minutes for three hours, more than 90% of healthy cells were observed in the 
field of view. With pulsed excitation at 365 nm (as in Figure 8), even shorter UV exposure 
times occur. 
12   
Thus, the more widespread use of 355 to 385 nm excitation in cellular optical 
imaging analysis should be encouraged, as the enhanced resolution that can be achieved is not 
compromised by phototoxicity when low-power pulsed excitation is used.  
  Examples of responsive probes have also been defined, based on these very bright 
complexes, in which the Eu spectral fingerprint and lifetime is a sensitive and selective 
function of local pH or ionic composition. 
30,35,43,44
 For example, the reversible intramolecular 
ligation of the sulphonamide nitrogen in [Eu.L
21
] is a function of pH. This complex localizes 
well to the endoplasmic reticulum, an organelle that is in equilibrium with the cytosol, so the 
pH is equivalent. Careful calibration studies allowed the ratio of two Eu emission bands or the 
modulation of the emission lifetime to signal pH variation (Figure 9).
44
  Related examples can 
be imagined, based on reversible anion binding to the Eu centre, 
43 
provided that the probe is 
able to target the organelle of interest selectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9    pH variation of the Eu 
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emission intensity ratio (J = 2/(J = 0 +J = 1) and excited state lifetime (τ) for [Eu.L21] (pKa = 7.15 
±0.05), when the probe is localized selectively in the endoplasmic reticulum of mouse skin fibroblasts 
(NIH-3T3 cells). 
44
 
 
  
Bioassays based on FRET   
The uptake of Eu complexes into cells by macropinocytosis is a disadvantage if you want to 
develop cellular assays for membrane bound proteins, such as the ubiquitous G-protein 
coupled receptors. 
45 45   
Random labeling of proteins or cellular compartments or the binding 
to immature proteins within the cytosol will mask the protein or protein-ligand interactions of 
interest, reducing the dynamic range of the assay. 
4a
 Bio-conjugates of highly water-soluble 
europium complexes are needed that have low non-specific interactions at concentrations of 
less than 1 M. The cell membrane consists primarily of negatively charged phospholipids, so 
that several series of 9-N3 based complexes have been devised that are highly water soluble 
and negatively charged at physiological pH (Figure 5 above). 
33
 Any interaction with the cell 
membrane is suppressed by repulsive electrostatic interactions. Furthermore, the hydrophilic 
nature of the integral sulphonate and carboxylate groups masks the inherent hydrophobic 
nature of the three aryl-alkynyl groups, as these are the likely entities that engage in non-
specific cell-surface protein or membrane binding.  
In one example, three europium complexes, [Eu.L
22-24
] (Figure 10) have been compared, one 
of which, [Eu.L
22
] served as a negative control, as it did not possess peripheral anionic 
substituents. The complexes were evaluated using ‘SNAP-tag’ technology 46 on the G-protein 
coupled receptor, cholecystokinin-2 (CCK-2). The labeling of the three benzylguanine-
derivatives was measured on living human embryonic kidney cells (HEK293), expressing the 
‘SNAP-tagged’ CCK-2 (SNAP-CCK2) receptor, by monitoring the Eu luminescence at 620 
nm. Significant labelling of the unmodified HEK293 cells occurred with [Eu.L
22
], whereas in 
the other two cases, non-specific labeling was negligible. Such behaviour paved the way for 
time-resolved FRET ligand binding assays using an agonist of the CCK receptor, labeled with 
a fluorophore  (em 665 nm) that serves as an acceptor for the long-lived emission from the Eu 
donor. These assays were undertaken both on a plate reader (Figure 11) and using TR-FRET 
microscopy. 
33   
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Figure 10          Schematic retrosynthetic analysis of Eu complexes for a ‘SNAP-tagged’ assay.33  
 
  
 
         
       
 
Figure 11 a) Cartoon showing a TR-FRET ligand binding assay on HEK-293 cells expressing 
SNAP-CCK2 (adapted with permission from reference 4a).  b,c,d) Saturation curves for labeling HEK-
293 cells expressing SNAP-CCK2 and non-transfected cells at the cell surface, using time-resolved 
detection (620 ± 5 nm, 60-460 ms) with [Eu.L
22
], [Eu.L
23
] and [Eu.L
24
] respectively. e) Binding of 
CCK(26-33)-red to HEK-293 cells expressing SNAP-CCK2 labeled with 200 nM of [Eu.L
24
], 
monitored by following the 665/620 nm intensity ratio. Non-specific signal was measured by adding 
10mM of unlabelled CCK(26-33) f) Time-resolved (TR)-FRET competition binding assay, monitoring 
the dose-response curve for the displacement of CCK(26-33)-red by the CCK2 antagonist PD135158. 
33 
 
Conclusions and Outlook 
The EuroTracker
®
 series of emissive complexes based on triazacyclononane possess a 
brightness that is almost an order of magnitude greater than previously reported Eu(III) 
systems, and are brighter than the recombinant red fluorescent protein. 
12
 The ease of 
structural manipulation allows close control over the absorption wavelength, over the range 
from 330 to 360 nm, and permits various points of attachment to targeting vectors or for 
biomolecule labeling. The disubstituted series of complexes possess one coordinated water 
molecule, yet retain a high quantum yield and bind anions reversibly. 
30
 Appropriate 
substitution of the third ring N, and careful control of the steric demand at the Eu centre 
should enable the development of new examples whose emission spectral profile and lifetime 
can be rendered sensitive to pH, pM and pX, with the required selectivity for the analyte 
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chosen in the background medium used. Enantiopure complexes can be obtained by C-
substitution into the nine-membered macrocyclic ring, aiding the development of chiral 
probes and tags for the exploration of CPL spectroscopy and microscopy. 
34
 
The series of amphipathic complexes that are efficiently taken into many mammalian cells by 
macropinocytosis are non-toxic and localise selectively in certain organelles,  allowing them 
to function as selective stains for live-cell imaging studies. By introducing peripheral anionic 
groups on the ‘rod-like’ chromophore groups, non-specific protein binding is suppressed and 
cell uptake is inhibited. This finding will allow various conjugates to be devised in the 
development of further organelle-targeted cellular stains and probes. Furthermore, the 
development of new series of bioassays is feasible, extending the scope and utility of time-
resolved FRET analyses, both in vitro and in cellulo. 
  
Evidently, the future is bright for these red-emitting complexes; Sir George Stokes might 
have approved.   
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